JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2001; 37:392-397
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linke, A.
Right arrow Articles by Hambrecht, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linke, A.
Right arrow Articles by Hambrecht, R.

CLINICAL STUDY: HEART FAILURE

Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training

Axel Linke, MDa, Nina Schoene, MDa, Stephan Gielen, MDa, J.ürgen Hofer, BSca, Sandra Erbs, MDa, Gerhard Schuler, MDa and Rainer Hambrecht, MDa

a University of Leipzig, Heart Center, Division of Cardiology, Leipzig, Germany

Manuscript received January 21, 2000; revised manuscript received August 18, 2000, accepted October 2, 2000.

Reprint requests and correspondence: Priv.-Doz. Dr. med. Rainer Hambrecht, Associate Professor of Medicine, University of Leipzig, Heart Center, Department of Internal Medicine/Cardiology, Russenstrasse 19, Leipzig 04289, Germany
hamr{at}server3.medizin.uni-leipzig.de


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
OBJECTIVES

We sought to analyze the systemic effects of lower-limb exercise training (ET) on radial artery endothelial function in patients with chronic heart failure (CHF).

BACKGROUND

Local ET has the potential to improve local endothelial dysfunction in patients with CHF. However, it remains unclear whether the systemic effects can be achieved by local ET.

METHODS

Twenty-two male patients with CHF were prospectively randomized to either ET on a bicycle ergometer (ET group, n = 11; left ventricular ejection fraction [LVEF] 26 ± 3%) or an inactive control group (group C, n = 11; LVEF 24 ± 2%). At the beginning of the study and after four weeks, endothelium-dependent and -independent vasodilation of the radial artery was determined by intra-arterial infusion of acetylcholine (ACh—7.5, 15 and 30 µg/min) and nitroglycerin (0.2 mg/min). The mean internal diameter (ID) of the radial artery was assessed using a high resolution ultrasound system (NIUS-02, Asulab Research Laboratories, Neuchâtel, Switzerland) with a 10-MHz probe.

RESULTS

After four weeks of ET, patients showed a significant increase in the baseline-corrected mean ID in response to ACh (30 µg/min), from 33 ± 10 to 127 ± 25 µm (p < 0.001 vs. control group at four weeks). In the control group, the response to ACh (30 µg/min) remained unchanged. Endothelium-independent vasodilation was similar in both groups at the beginning of the study and at four weeks. In the training group, increases in agonist-mediated, endothelium-dependent vasodilation correlated to changes in functional work capacity (r = 0.63, p < 0.05).

CONCLUSIONS

In patients with stable CHF, bicycle ergometer ET leads to a correction of endothelial dysfunction of the upper extremity, indicating a systemic effect of local ET on endothelial function.

Abbreviations and Acronyms
  ACh = acetylcholine
  BP = blood pressure
  CHF = chronic heart failure
  eNOS = endothelial nitric oxide synthase
  ET = exercise training
  FDVD = flow-dependent vasodilation
  ID = internal diameter
  LVEF = left ventricular ejection fraction
  NO = nitric oxide
  NTG = nitroglycerin
  NYHA = New York Heart Association


The last decade has witnessed a paradigmatic shift from the concept of chronic heart failure (CHF) as a "pump disorder" to the growing understanding of heart failure as a systemic neurohormonal disease, in which alterations of skeletal muscle and increased systemic vasomotor tone with impaired peripheral perfusion contribute to a reduced exercise capacity (1,2). Peripheral vasoconstriction in CHF has been explained by neurohormonal changes like activation of the sympathetic nervous system and the renin-angiotensin system (3,4). In recent years, however, the major role of the vascular endothelium in regulating local vasomotor tone has been revealed (5,6). Endothelial cells regulate vascular diameter by releasing nitric oxide (NO). Its production and release are influenced by endocrine mediators like acetylcholine (ACh) (through muscarinic receptors); mechanical, receptor-independent stimuli (shear stress); and the availability of the NO precursor, L-arginine. Different cardiovascular diseases (i.e., arterial hypertension, coronary artery disease, CHF) are associated with an attenuated vasodilatory response to ACh, as well as impaired flow-dependent vasodilation (FDVD) (7,8).

Cell culture experiments have indicated that shear stress induces an upregulation of the endothelial NO synthase (eNOS) (9). In animal studies, regular physical exercise training (ET) enhances endothelium-dependent vasodilation of conduit coronary arteries (10,11), suggesting that the in vitro results may be relevant for endothelial function in vivo. The positive effects of physical training on endothelial dysfunction could also be documented in patients with CHF. Local training interventions like handgrip exercise (12–14) or bicycle ergometer training improve local flow-dependent, endothelium-mediated vasodilation (15). However, these studies demonstrated only local effects of physical ET on endothelial dysfunction of the trained extremity.

It has been a matter of continuing debate whether there is a critical proportion of the whole body muscle mass that has to be trained to achieve systemic effects on endothelial function. Recently, it has been shown that 10 weeks of lower-limb endurance training in healthy subjects with normal endothelial function have systemic effects on agonist-mediated, endothelium-dependent vasodilation (16).

It remains unclear, however, whether the systemic endothelial effects can also be achieved by local ET in patients with CHF, whose endothelial function is severely compromised. Therefore, the objective of the present study was to investigate whether lower-limb ET in patients with CHF has the potential to correct endothelial dysfunction of the upper extremity, indicating systemic rather than local changes of vascular function.


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Subjects.   Twenty-two male patients age ≤70 years with CHF due to dilated cardiomyopathy or ischemic heart disease were studied. The diagnosis of heart disease was based on cardiac catheterization. Left ventricular ejection fraction (LVEF) was <40%, as assessed by left ventriculography. All patients were in stable clinical condition for three months before enrollment and had clinical, radiologic and echocardiographic signs of CHF (New York Heart Association [NYHA] functional class II/III). At baseline, a symptom-free exercise capacity of ≥25 W on bicycle ergometry was required.

Exclusion criteria included any conditions potentially affecting endothelial function, such as arterial hypertension (>160/90 mm Hg), hypercholesterolemia (total cholesterol >6.0 mmol/liter), diabetes mellitus (fasting glucose >6.5 mmol/liter) and current smoking. Patients with heart failure due to valvular heart disease were also excluded from the study.

Study protocol.   The study was approved by the Ethics Committee of the University of Leipzig, and written, informed consent was obtained from all patients.

At baseline, all patients performed a symptom-limited, maximal ET on a calibrated, electronically braked bicycle in an upright position. Work load was increased by 25 W every 3 min beginning at 25 W. Respiratory gas exchange was determined continuously throughout the ET, as previously described (15,17). Oxygen consumption was determined at a maximal work load and at the ventilatory threshold. The ventilatory threshold was defined as the oxygen uptake before the systematic increase in the ventilatory equivalent for oxygen, without a concomitant increase in the ventilatory equivalent for carbon dioxide (18).

One day after the maximal ET, endothelial function was studied in the fasting state in a quiet and temperature- and humidity-controlled room. All cardiovascular medications were withheld for >24 h before assessment of endothelium-dependent vasodilation.

Randomization.   After baseline measurements, patients were randomized to either a training or control group.

The patients assigned to the training program stayed in the hospital for the period of the study. They exercised 6 times/day for 10 min on a bicycle ergometer under close supervision, at 70% peak oxygen consumption. The patients in the control group received their previous medications, continued their sedentary life-style and were supervised by their private physician.

High precision ultrasound and determination of arterial diameter.   For intra-arterial infusion of ACh and nitroglycerin (NTG), a 20-gauge catheter was placed into the brachial artery. Vessel diameter was measured as previously described (14). In brief, after a rest period of 20 min in the supine position, the internal diameter (ID) of the radial artery was determined using a high precision A-mode tracking ultrasound system, which permits measurement of the vessel diameter with a precision of ±2 µm (NIUS-02, Asulab Research Laboratories, Neuchâtel, Switzerland). A 10-MHz transducer was positioned perpendicular to the radial artery about 5 cm proximal to the wrist, without direct skin contact. Blood flow velocity was recorded simultaneously using an 8-MHz Doppler probe (Doptek 2003, Deltex France SA, Montpellier, France). Blood flow (ml/min) was calculated as the average peak velocity x cross-sectional area.

Intra-arterial infusions.   Baseline measurements of the arterial diameter were performed by infusing a 5% glucose solution (Glucosteril 5%, Pharmacia, Erlangen, Germany) at a constant rate of 1 ml/min for 5 min. Endothelium-dependent vasodilation was assessed using ACh (Miochol Ciba-Vision, Grossostheim, Germany) in increasing doses: 7.5, 15 and 30 µg/min were administered at a flow rate of 1 ml/min for 5 min at each concentration step.

For determination of FDVD, the brachial artery was occluded by inflating the blood pressure (BP) cuff to 50 mm Hg above the systolic BP for 5 min. The ID of the radial artery was recorded continuously for 2 min in 10-s intervals after deflation of the occlusion cuff. The maximal ID was recorded as a measure of FDVD.

Endothelium-independent vasodilation was determined using NTG (Glyceroltrinitrat, Schwarz Pharma, Monheim, Germany) at a dose of 0.2 mg/min and a flow rate of 1 ml/min. Between each intervention, the infusions were stopped for 2 min to allow the radial artery diameter to return to baseline values.

Statistical analysis.   All data are expressed as the mean value ± SEM. The data were tested for normal distribution using the Kolmogorov-Smirnov test, and for homogeneity of variances using Levene’s test.

Absolute values, baseline-corrected IDs (difference between ID during infusion of the respective agonist and ID during glucose infusion) and percent changes from baseline were used for statistical analyses. Both intragroup and intergroup comparisons were made using two-way repeated measures analysis of variance (ANOVA), followed by the Tukey post hoc test. For the ANOVA procedure, both the results of the test for the interaction between group and time and the results of the Tukey post hoc test are reported. In case of non-normal distribution, intragroup comparisons were performed using the Wilcoxon signed-rank test; intergroup comparisons were done using the Mann-Whitney U test.

The relation between changes in endothelium-dependent vasodilation and increases in peak oxygen consumption was assessed by linear regression analysis. A p value <0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Patient characteristics.   At baseline, patients in the training and control groups did not differ significantly in terms of age, etiology of heart failure, NYHA functional class, LVEF or left ventricular end-diastolic diameter. They had similar values for blood glucose, total cholesterol and systolic and diastolic arterial pressure (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1 Patient Characteristics

 
Medical treatment.   All patients were on angiotensin-converting enzyme inhibitors, 73% were on diuretics, 54% were on digoxin and 59% were on beta-blockers. Medical therapy did not differ significantly between the two groups. Drug treatment was not changed in any patient between at least four weeks before enrollment and study termination (Table 2).


View this table:
[in this window]
[in a new window]
 
Table 2 Medical Treatment

 
Baseline measurements.   At the beginning of the study, a slight but significant difference in vessel diameter between the training and control groups was noted during glucose infusion: training group 3.42 ± 0.12 mm versus control group 2.99 ± 0.13 mm (p < 0.05). However, patients in the training and control groups had similar responses to ACh, NTG and flow (Table 3), as assessed by the percent change in radial artery diameter. There were no significant differences in oxygen uptake at the ventilatory threshold (11.5 ± 0.9 vs. 11.5 ± 0.9 ml/kg per min) or at peak exercise (16.0 ± 1.2 vs. 16.9 ± 1.3 ml/kg per min) between training and control groups.


View this table:
[in this window]
[in a new window]
 
Table 3 Changes in Internal Diameter of the Radial Artery After Acetylcholine, Nitroglycerin and Reactive Hyperemia at the Beginning of the Study and After Four Weeks

 
Vasodilative responses to ACh.   After four weeks of ET, ACh-mediated, endothelium-dependent vasodilation increased significantly from 33 ± 10 to 127 ± 25 µm (p < 0.001 vs. control group at four weeks), from 114 ± 31 to 290 ± 47 µm (p < 0.001 vs. control group at four weeks) and from 184 ± 57 to 453 ± 63 µm (p < 0.001 vs. control group at four weeks) at 7.5, 15 and 30 µg/min of ACh, respectively. In the control group, the response to ACh remained virtually unchanged during the study period (Fig. 1).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1 Individual changes of the endothelium-dependent, vasodilative response to ACh at a dose of 30 µg/min at the beginning of the study and after four weeks of ET (left panel) and in control subjects (right panel). The percent changes in ID, as compared with baseline diameter (5% glucose infusion), are provided. *p < 0.001 vs. beginning of study. ##p < 0.001 vs. control group.

 
Vasodilative response to NTG.   Bicycle ergometer training did not change the endothelium-independent vasodilatory capacity of the radial artery. In the training group, infusion of NTG led to a comparable increase in the ID of the radial artery at beginning and end of the study (594 ± 47 vs. 602 ± 56 µm, p = 0.563). In parallel, the endothelium-independent vasodilative capacity remained unchanged in the control group.

Flow-dependent vasodilation.   Four weeks of bicycle ergometer training were associated with a significant increase in FDVD, from 374 ± 57 to 570 ± 76 µm (p < 0.01 vs. control group at four weeks); in the control group, FDVD remained essentially unchanged (344 ± 20 µm at the beginning of the study vs. 351 ± 22 µm at four weeks).

Exercise capacity.   Four weeks of aerobic ET led to a significant increase in oxygen consumption at the ventilatory threshold and at peak exercise, by 19 ± 5% (from 11.5 ± 0.9 to 13.4 ± 0.9 ml/kg per min, p < 0.001 vs. beginning of study; p = 0.004 for interaction [ANOVA]) and by 21 ± 2% (from 16.0 ± 1.2 to 19.4 ± 1.4 ml/kg per min, p < 0.001 vs. beginning of study; p < 0.001 for interaction [ANOVA]), respectively. In the control group, oxygen consumption at the ventilatory threshold and at peak exercise did not change between the beginning and end of the study (11.5 ± 0.8 vs. 11.3 ± 0.8 ml/kg per min and 16.9 ± 1.2 vs. 16.3 ± 1.3 ml/kg per min). One patient in the control group did not tolerate the mouth piece of the ergospirometer during exercise; therefore, complete respiratory data are available in 10 control subjects.

Correlation between improvement of endothelial function and exercise capacity.   Changes in agonist-mediated, endothelium-dependent vasodilation (ACh [30 µg/min]) induced by ET were significantly correlated with changes in peak oxygen consumption (r = 0.63, p < 0.05) (Fig. 2).



View larger version (14K):
[in this window]
[in a new window]
 
Figure 2 Correlation between change (four weeks vs. beginning of study) in peak oxygen consumption (VO2max) and change in endothelium-dependent, vasodilative response (ID at four weeks – ID at beginning of study) to ACh (30 µg/min) in the ET group.

 

    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
The present study may extend our current concept of the effects of ET on vascular endothelial function in two regards: 1) regular ET on the cycle ergometer has systemic effects on endothelial function in patients with CHF; and 2) improvement in the endothelium-dependent vasodilative capacity is correlated with an increase in exercise capacity after four weeks of regular ET.

Effects of ET on endothelium-dependent vasodilation.   In patients with CHF, endothelium-dependent vasodilation of peripheral vessels is impaired (7), possibly as a result of impaired eNOS activity (8,15). Physical ET increases shear stress by intermittently augmenting pulsatile flow along the endothelium. During handgrip exercise, the increase in pulsatile flow remains restricted to the forearm vessels. In bicycle ergometer training, however, the trained muscle mass exceeds the critical proportion necessary to achieve systemic cardiovascular effects. Although one is inclined to presume that the highest increase in blood flow—and thus the most pronounced shear stress effects—will be in the vasculature supplying the exercised muscles, the increases in heart rate and BP amplitude during the training program systemically increase pulsatile flow. In an independent parallel study, a 10-week program of aerobic and anaerobic ET in healthy young men led to a systemic enhancement of endothelial function (16). The present study extends these findings to pathologic states. To our knowledge, it is the first to prove the systemic effects of lower-limb ET in patients with CHF. Four weeks of bicycle ergometer ET at a submaximal level led to a significant improvement of endothelial function of the upper extremity. The vasodilatory response to ACh at the highest concentration increased 2.5-fold, whereas FDVD improved by 50%. Other factors potentially influencing vascular endothelial function, such as blood glucose, serum cholesterol levels and arterial BP, remained unchanged during the study period. A possible alternative hypothesis could be that ET induces changes in circulating humoral factors, which, in turn, affect endothelial function. However, no data on the short-term influences of ET on catecholamines, for example, in patients with CHF are available thus far.

Our results contrast with those of a previous study by Demopoulos et al. (19), who failed to show any effect of bicycle ergometer training on endothelial function of the untrained upper extremity. Several differences of the present study may explain the divergent findings: 1) ET was performed at a significantly lower intensity, which may not have had the effects on BP amplitude necessary to attain systemic effects; 2) the patients studied by Demopoulos et al. (19) were in more advanced stages of heart failure; and 3) their methodologic approach for measuring endothelial function differed from that of our study (forearm venous occlusion plethysmography vs. high resolution ultrasound).

Correlation between endothelium-dependent vasodilation and exercise capacity.   In a previous study involving patients with CHF, we found a correlation between changes in endothelium-dependent vasodilation and changes in functional work capacity (15). In accordance with this observation, changes in endothelium-dependent vasodilatory capacity were related to changes in peak oxygen uptake in the present study. The correlation between improvement of endothelial vasodilatory function and functional work capacity implies that by improving endothelial dysfunction, exercised-induced peripheral perfusion is augmented, which, in turn, leads to a higher exercise capacity.

Effects of ET on FDVD.   Endothelial dysfunction in CHF is not restricted only to agonist-mediated vasodilation; it also affects FDVD during reactive hyperemia (12). During reactive hyperemia, the maximal vasodilation occurs ~40 to 60 s after release of arterial occlusion (20). In animal as well as in human studies, it could be shown that FDVD is mediated partly by endothelium-derived NO (21–23). The proportion of FDVD inhibited by NG-monomethyl L-arginine (L-NMMA), an eNOS inhibitor, increases significantly after ET in patients with CHF (12,15). These results indicate an increased basal activity of eNOS after ET, which may be indicative of eNOS upregulation after training, as previously described in animal experiments (9,10).

Because endothelial factors contribute substantially to reactive hyperemia, we expected significant changes after ET. Maximal FDVD was significantly enhanced after ET by 54%.

Effects of ET on endothelium-independent vasodilation.   Like other cardiovascular diseases, CHF is associated with increased oxidative stress. Reactive oxygen species, such as superoxide anions (O2) rapidly scavenge NO, leading to an accelerated breakdown of NO, and consequently, an impairment of endothelial function (24,25). In a recently published clinical study, Hornig et al. (26) demonstrated that the early and late application of the radical scavenger vitamin C, improves flow-induced, NO-mediated vasodilation in forearm vessels of patients with CHF. In cell culture experiments, shear stress was associated with an upregulation of the cytosolic copper/zinc–containing superoxide dismutase, a free radical scavenger enzyme (27). Thus, the inactivation of NO by vascular superoxide anions or other reactive oxygen species may be attenuated after ET.

The fact that we did not find any differences in endothelium-independent vasodilation after training may indicate either that NTG was administered in sufficient excess above any reactive oxygen species or that a longer training intervention may be necessary to influence endothelium-independent vasodilation.

Clinical implications.   In the present study, we demonstrated that four weeks of lower-limb aerobic ET corrects radial artery endothelial dysfunction in patients with CHF. The finding that the beneficial effects of training are not confined to the trained extremity indicates a systemic effect on endothelial function. Our study implies that endothelial dysfunction will be systemically improved as soon as a critical muscle mass is trained at a level sufficient to increase BP amplitude and shear stress. This message has important implications for ongoing trials investigating the effects of local ET in advanced stages of CHF.


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 

  1. Minotti JR, Christoph I, Oka R, Weiner MW, Wells I, Massie BM. Impaired skeletal muscle function in patients with congestive heart failure: relationship to systemic exercise performance. J Clin Invest. 1991;88:2077–2082[Medline]
  2. Massie BM. Exercise intolerance in congestive heart failure: role of cardiac function, peripheral blood flow, and muscle metabolism and effect of treatment. Am J Med. 1988;84:75–82[Medline]
  3. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PL. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615–621[Abstract/Free Full Text]
  4. Francis GS, Rector RS, Cohn JN. Sequential neurohumoral measurements in patients with congestive heart failure. Am Heart J. 1988;116:1464–1468[CrossRef][Medline]
  5. Furchgott RF, Zawadzki JV, Jothiananda D. The obligatory role of endothelial cells in the relaxtion of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–376[CrossRef][Medline]
  6. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997–1000[Medline]
  7. Kubo SH, Rector TC, Williams RE, Heifritz SM, Bank AJ. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84:1589–1596[Abstract/Free Full Text]
  8. Katz SD, Krum H, Kahn T, Knecht M. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol. 1996;28:585–590[Abstract]
  9. Nishida K, Harrison DG, Navas JP, et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest. 1992;90:2092–2096[Medline]
  10. Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74:349–353[Abstract/Free Full Text]
  11. Wang J, Wolin MS, Hintze T. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary arteries in conscious dogs. Circ Res. 1993;73:829–838[Abstract/Free Full Text]
  12. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation. 1996;93:210–214[Abstract/Free Full Text]
  13. Katz SD, Yuen J, Bijou R, LeJemtel TH. Training improves endothelium-dependent vasodilation in resistance vessels of patients with heart failure. J Appl Physiol. 1997;82:1488–1492[Abstract/Free Full Text]
  14. Hambrecht R, Hilbrich L, Erbs S, et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol. 2000;35:706–713[Abstract/Free Full Text]
  15. Hambrecht R, Fiehn E, Weigl C, et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation. 1998;98:2709–2715[Abstract/Free Full Text]
  16. Clarkson P, Montgomery HE, Mullen MJ, et al. Exercise training enhances endothelial function in young men. J Am Coll Cardiol. 1999;33:1379–1385[Abstract/Free Full Text]
  17. Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscle. J Am Coll Cardiol. 1995;25:1239–1249[Abstract]
  18. Wassermann K, Whipp BJ, Koyal SH, Beaver WL. Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol. 1973;35:236–243[Free Full Text]
  19. Demopoulos L, Bijou R, Fergus I, Jones M, Strom J, LeJementel TH. Exercise training in patients with severe congestive heart failure: enhancing peak aerobic capacity while minimizing the increase in ventricular wall stress. J Am Coll Cardiol. 1997;29:597–603[Abstract]
  20. Hintze TH, Vatner SF. Reactive dilation of large coronary arteries in conscious dogs. Circ Res. 1984;54:50–57[Abstract/Free Full Text]
  21. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314–1319[Abstract/Free Full Text]
  22. Holtz J, Forstermann U, Pohl U. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. J Cardiovasc Pharmacol. 1984;6:1161–1169[Medline]
  23. Engelke K, Halliwill J, Proctor D. Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm. J Appl Physiol. 1996;81:1807–1814[Abstract/Free Full Text]
  24. Bouloumie A, Bauersachs J, Linz W, et al. Endothelial dysfunction coincides with an enhanced NO synthase expression and superoxide production. Hypertension. 1997;30:934–941[Abstract/Free Full Text]
  25. Nava E, Noll G, Lüscher T. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation. 1995;91:2310–2313[Abstract/Free Full Text]
  26. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation. 1998;97:363–368[Abstract/Free Full Text]
  27. Inoue N, Ramasamy S, Fukai T, Nerem RM, Harrison DG. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res. 1996;79:32–37[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Biol Res NursHome page
M.-K. Tai, J. C. Meininger, and L. Q. Frazier
A Systematic Review of Exercise Interventions in Patients With Heart Failure
Biol Res Nurs, October 1, 2008; 10(2): 156 - 182.
[Abstract] [PDF]


Home page
J. Appl. Physiol.Home page
D. H. J. Thijssen and M. T. E. Hopman
Counterpoint: Exercise training does not induce vascular adaptations beyond the active muscle beds
J Appl Physiol, September 1, 2008; 105(3): 1004 - 1006.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. C. Poole, B. J. Behnke, T. I. Musch, M. Sandri, S. Gielen, O. J. Kemi, O. Rognmo, U. Wisloff, P. M. Haram, S. B. Bender, et al.
Comments on point: counterpoint: exercise training does/does not induce vascular adaptations beyond the active muscle beds.
J Appl Physiol, September 1, 2008; 105(3): 1008 - 1009.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. J. Green, A. J. Maiorana, and N. T. Cable
Point:Counterpoint: Exercise training does/does not induce vascular adaptations beyond the active muscle beds
J Appl Physiol, September 1, 2008; 105(3): 1002 - 1004.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Ventura-Clapier, B. Mettauer, and X. Bigard
Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure
Cardiovasc Res, January 1, 2007; 73(1): 10 - 18.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. L. McGowan, A. S. Levy, P. J. Millar, J. C. Guzman, C. A. Morillo, N. McCartney, and M. J. MacDonald
Acute vascular responses to isometric handgrip exercise and effects of training in persons medicated for hypertension
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1797 - H1802.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. S. Gottlieb and I. L. Pina
Enhanced External Counterpulsation: What Can We Learn From the Treatment of Neurasthenia?
J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1206 - 1207.
[Full Text] [PDF]


Home page
CirculationHome page
J. Cui, A. Arbab-Zadeh, A. Prasad, S. Durand, B. D. Levine, and C. G. Crandall
Effects of Heat Stress on Thermoregulatory Responses in Congestive Heart Failure Patients
Circulation, October 11, 2005; 112(15): 2286 - 2292.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Sandri, V. Adams, S. Gielen, A. Linke, K. Lenk, N. Krankel, D. Lenz, S. Erbs, D. Scheinert, F. W. Mohr, et al.
Effects of Exercise and Ischemia on Mobilization and Functional Activation of Blood-Derived Progenitor Cells in Patients With Ischemic Syndromes: Results of 3 Randomized Studies
Circulation, June 28, 2005; 111(25): 3391 - 3399.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Rakobowchuk, C. L. McGowan, P. C. de Groot, J. W. Hartman, S. M. Phillips, and M. J. MacDonald
Endothelial function of young healthy males following whole body resistance training
J Appl Physiol, June 1, 2005; 98(6): 2185 - 2190.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. W. P. Bleeker, M. Kooijman, G. A. Rongen, M. T. E. Hopman, and P. Smits
Preserved contribution of nitric oxide to baseline vascular tone in deconditioned human skeletal muscle
J. Physiol., June 1, 2005; 565(2): 685 - 694.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. J. Green, W. Bilsborough, L. H. Naylor, C. Reed, J. Wright, G. O'Driscoll, and J. H. Walsh
Comparison of forearm blood flow responses to incremental handgrip and cycle ergometer exercise: relative contribution of nitric oxide
J. Physiol., January 15, 2005; 562(2): 617 - 628.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. J Green, A. Maiorana, G. O'Driscoll, and R. Taylor
Effect of exercise training on endothelium-derived nitric oxide function in humans
J. Physiol., November 15, 2004; 561(1): 1 - 25.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Guazzi, G. Reina, G. Tumminello, and M. D. Guazzi
Improvement of alveolar-capillary membrane diffusing capacity with exercise training in chronic heart failure
J Appl Physiol, November 1, 2004; 97(5): 1866 - 1873.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V. M. Conraads, P. Beckers, J. Vaes, M. Martin, V. Van Hoof, C. De Maeyer, N. Possemiers, F. L. Wuyts, and C. J. Vrints
Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure
Eur. Heart J., October 2, 2004; 25(20): 1797 - 1805.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Green, J. H. Walsh, A. Maiorana, M. J. Best, R. R. Taylor, and J. G. O'Driscoll
Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2679 - H2687.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. H. Walsh, G. Yong, C. Cheetham, G. F. Watts, G. J. O'Driscoll, R. R. Taylor, and D. J. Green
Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects
Eur. Heart J., September 2, 2003; 24(18): 1681 - 1689.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. H. Walsh, W. Bilsborough, A. Maiorana, M. Best, G. J. O'Driscoll, R. R. Taylor, and D. J. Green
Exercise training improves conduit vessel function in patients with coronary artery disease
J Appl Physiol, July 1, 2003; 95(1): 20 - 25.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Q. Stolen, J. Kemppainen, H. Ukkonen, K. K. Kalliokoski, M. Luotolahti, P. Lehikoinen, H. Hamalainen, T. Salo, K. E. Juhani Airaksinen, P. Nuutila, et al.
Exercise training improves biventricular oxidative metabolism and left ventricular efficiency in patients with dilated cardiomyopathy
J. Am. Coll. Cardiol., February 5, 2003; 41(3): 460 - 467.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V.M. Conraads, P. Beckers, J. Bosmans, L.S. De Clerck, W.J. Stevens, C.J. Vrints, and D.L. Brutsaert
Combined endurance/resistance training reduces plasma TNF-{alpha} receptor levels in patients with chronic heart failure and coronary artery disease
Eur. Heart J., December 1, 2002; 23(23): 1854 - 1860.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Green, C. Cheetham, C. Henderson, R. Weerasooriya, and G. O'Driscoll
Effect of cardiac pacing on forearm vascular responses and nitric oxide function
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1354 - H1360.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Green, C. Cheetham, L. Mavaddat, K. Watts, M. Best, R. Taylor, and G. O'Driscoll
Effect of lower limb exercise on forearm vascular function: contribution of nitric oxide
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H899 - H907.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. Green, C. Cheetham, C. Reed, L. Dembo, and G. O'Driscoll
Assessment of brachial artery blood flow across the cardiac cycle: retrograde flows during cycle ergometry
J Appl Physiol, July 1, 2002; 93(1): 361 - 368.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Chandrruangphen and P. Collins
Exercise-Induced Suppression of Postprandial Lipemia: A Possible Mechanism of Endothelial Protection?
Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1239 - 1239.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Maiorana, G. O'Driscoll, C. Cheetham, L. Dembo, K. Stanton, C. Goodman, R. Taylor, and D. Green
The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 860 - 866.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linke, A.
Right arrow Articles by Hambrecht, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linke, A.
Right arrow Articles by Hambrecht, R.


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK